TheraVet announces a strategic transformation project aimed at creating a leader in human idiopathic pulmonary fibrosis
The proposed Operation is part of the strategic transformation project between TheraVet and H4 Orphan Pharma aimed at developing the H4 Orphan Pharma's flagship clinical program in idiopathic pulmonary fibrosis and capitalizing…
0 commentaire
23 octobre 2024